CONCURRENT TARGETING OF ONCOGENIC PATHWAYS TO ENHANCE CHEMOTHERAPY AND IMMUNOTHERAPY

The present invention relates to the field of cancer. More specifically, the present invention provides compositions and methods for treating cancer by targeting YAP1 and STAT3 pathways. In a specific embodiment, the present invention provides a method for increasing sensitivity of cancer in a subje...

Full description

Saved in:
Bibliographic Details
Main Authors HOQUE, Mohammad, SADHUKHAN, Pritam
Format Patent
LanguageEnglish
French
German
Published 05.06.2024
Subjects
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the field of cancer. More specifically, the present invention provides compositions and methods for treating cancer by targeting YAP1 and STAT3 pathways. In a specific embodiment, the present invention provides a method for increasing sensitivity of cancer in a subject to chemotherapy and/or immunotherapy comprising the step of administering to the subject an effective amount of a YAP1 inhibitor and a STAT3 inhibitor.
Bibliography:Application Number: EP20220850563